Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 21:35:55 - browse：67

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Gene therapy for Afghan refugees’ infant will be fully covered

Wikipedia

WSS

WATCH: Why do bright lights make us see spots?

Surgery pushed Ben Carson to fame

New weight loss drugs vying to be the next Wegovy or Mounjaro

IRA could hurt research into orphan drugs for rare diseases

FDA proposes changes to key medical devices approval pathway

Why Novartis is going to walk from its acquisition of MorphoSys

explore

Wikipedia

Sign up for D.C. Diagnosis

focus

Hepatitis C has a cure — but many Americans still lack access to it

Bernie brings in new pharma CEOs to talk drug prices

After affirmative action ruling, medical educators look to 'holistic review'

The CDC's new social media misinformation war

What does generative AI mean for health care? We asked experts

Hospitals consider fixing cancer drug shortages on their own

Activists slam private health insurers over coverage restrictions

Telehealth for opioid use disorder is lifesaving

Continuity nursing helped my family in our darkest PICU moments

Regeneron agrees to White House price limits on anti

explore

Texas Medical Board asked to define abortion emergency exception

Regeneron agrees to White House price limits on anti

Will the IRA bring competition to the biologics market?

How to make the FDA’s new prescription one

Texas Medical Board asked to define abortion emergency exception

Devoted Health’s losses in Medicare Advantage persist

Wikipedia

explore

focus

leisure time